Literature DB >> 16796305

Learning curve for add-on stereotactic core needle breast biopsy.

A Koskela1, M Berg, M Sudah, A Malinen, V Kärjä, P Mustonen, V Kataja, S Soimakallio, R Vanninen.   

Abstract

PURPOSE: To evaluate the learning curve for an add-on 14 G stereotactic core needle biopsy (SCNB).
MATERIAL AND METHODS: A total of 231 non-palpable breast lesions that had undergone add-on SCNB were evaluated in this prospective study. Five radiologists performed their first three biopsies under supervision. Subsequent, independently performed, biopsies were also evaluated. The samples were collected in three different containers: the first sample in container A, the second and third samples in container B, and subsequent samples in container C (available for four radiologists from the first biopsy on). Technically successful biopsies and false-negative rate in three container combinations (A, A+B, A+B+C) were reported as a function of operator experience.
RESULTS: Technically unsuccessful biopsies occurred significantly more often in microcalcifications than in masses (14.9% versus 3.8%; P=0.04). For microcalcifications, the rate of successful biopsies was 75% (18/24) for the first 5 biopsies and 87.8% (79/90) for the subsequent biopsies (P=0.335); rates for the masses were 95.7% (22/23) and 96.3% (79/82) (P=1.0), respectively. A tendency was noted for the false-negative rate to be higher for the first five biopsies in three container combinations than in subsequent cases.
CONCLUSION: Our results support the existence of a learning curve, especially in the biopsy of microcalcifications. More than three mentor-guided biopsies are needed.

Entities:  

Mesh:

Year:  2006        PMID: 16796305     DOI: 10.1080/02841850600702168

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  1 in total

1.  A comparative study on ultrasound-guided elite, Mammotome, and core needle biopsy for diagnosing malignant breast masses.

Authors:  Shi-Fang Zou; Lin Tao; Zhen-Chu Feng; Ji-Yan Wang; Lin Liu; Wen-Long Liang; Jie-Na Liu; Dan-Dan Xu; Jia-Yan Lin; Jian-Guo Zhang; Xi Chen
Journal:  Arch Med Sci       Date:  2019-08-22       Impact factor: 3.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.